1. The Need for Dementia Care Services

  1. Hugo de Waal MD, FRCPsych, FHEA2,
  2. Constantine Lyketsos MD, MHS3,
  3. David Ames BA, MD, FRCPsych, FRANZCP4 and
  4. John O'Brien BA, BM BCh, MA, FRCPsych, MD5
  1. Gill Livingston and
  2. Claudia Cooper

Published Online: 7 JUL 2013

DOI: 10.1002/9781118378663.ch1

Designing and Delivering Dementia Services

Designing and Delivering Dementia Services

How to Cite

Livingston, G. and Cooper, C. (2013) The Need for Dementia Care Services, in Designing and Delivering Dementia Services (eds H. de Waal, C. Lyketsos, D. Ames and J. O'Brien), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118378663.ch1

Editor Information

  1. 2

    Lead Consultant, Norfolk Dementia Care Academy, Norwich, UK

  2. 3

    Associate Postgraduate Dean, East of England Deanery, Cambridge, UK

  3. 4

    Elizabeth Plank Althouse Professor, Director of the Johns Hopkins Memory and Alzheimer's Treatment Center, Johns Hopkins Medicine, Maryland, USA

  4. 5

    Director, National Ageing Research Institute, University of Melbourne Professor of Ageing and Health, Victoria, Australia

Author Information

  1. Mental Health Sciences Unit, University College London, UK

Publication History

  1. Published Online: 7 JUL 2013

ISBN Information

Print ISBN: 9781119953494

Online ISBN: 9781118378663



  • dementia services;
  • evidence-based service configuration;
  • preventive dementia services;
  • risk factors for dementia;
  • early detection of dementia;
  • dementia screening programmes;
  • pre-dementia syndromes


As the number of people with dementia increases with ageing populations across the world and our knowledge improves, more and better services are needed. This chapter covers the services which we have at present and those which evidence indicates should be available. These are divided into prevention, treatment and care. The chapter discusses strategies to increase diagnosis, the advantages of early and active treatment of dementia and the dedicated services needed to achieve these. If current trials of disease modifying medications prove successful this will probably lead to further, radical changes in service configuration, possibly with screening programmes focused on the identification of pre-dementia syndromes and home treatments. Making these evidence based strategies available is now a global challenge.